Blocking the expression of syntaxin 4 interferes with initial phagocytosis of Brucella melitensis in macrophages

Alfredo Castañeda-Ramírez1, Diana González-Rodríguez1, J Aide Hernández-Pineda1

  • 1Laboratorio de Microbiología Molecular, Departamento de Microbiología e Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, CU, Distrito Federal 04510, México (Castañeda-Ramírez, González-Rodríguez, Hernández-Pineda, Verdugo-Rodríguez); Departamento de Zootecnia, Universidad Autónoma Chapingo, Texcoco, México (Castañeda-Ramírez).

Insights

Brucella melitensis survival in human macrophages depends on syntaxin 4 (STX4). Inhibiting STX4 significantly reduced B. melitensis survival, highlighting its role in early infection stages.

Area of Science:

  • Microbiology
  • Cell Biology
  • Immunology

Background:

  • Brucella melitensis causes human brucellosis and infects ruminants.
  • Pathogenesis of B. melitensis intracellular infection requires further elucidation, particularly host cell invasion events.

Purpose of the Study:

  • To investigate the role of syntaxin 4 (STX4) in the early stages of human macrophage infection by B. melitensis.
  • To determine if STX4 expression is altered during B. melitensis phagocytosis.

Main Methods:

  • Infection of THP-1 human macrophages with B. melitensis and Salmonella Enteritidis.
  • Analysis of syntaxin 4 (STX4) expression using immunoblot assays and mRNA analysis.
  • Silencing of STX4 mRNA using small interfering RNA (siRNA) to assess its impact on bacterial survival.

Main Results:

  • STX4 expression levels were comparable between B. melitensis and S. Enteritidis infected cells.
  • Inhibition of STX4 mRNA expression significantly reduced B. melitensis survival post-infection.
  • STX4 plays a crucial role in the survival of B. melitensis within human macrophages.

Conclusions:

  • Syntaxin 4 (STX4) is essential for the intracellular survival of Brucella melitensis.
  • Targeting STX4 could be a potential strategy to combat B. melitensis infections.

Related Concept Videos